Moderna (MRNA) Revenue (2017 - 2026)
Moderna (MRNA) posted Revenue of $145 million for Q2 2026, up 2.1% from $142 million a year earlier but down 62.7% from the prior quarter.
Moderna (MRNA) Revenue (2017 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Revenue at Moderna was $2.23 billion, down 27.6% year-over-year; for FY2025, it came in at $1.94 billion, down 39.9% from FY2024.
- Annual Revenue has declined for three consecutive years, though with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- In prior years, Moderna's Revenue was $3.24 billion in FY2024 (-52.7%), $6.85 billion in FY2023 (-64.4%), $19.26 billion in FY2022 (+4.3%) and $18.47 billion in FY2021.
- Quarterly Revenue has run from a low of $108 million in Q1 2025 to a high of $7.21 billion in Q4 2021 over five years.
- On a year-over-year basis, Revenue increased in three of the last eight quarters, with growth averaging 5.8%.
- The strongest year-over-year quarter for Revenue in the past five years was Q1 2026, with growth of 260.2%; the weakest was Q2 2023, with a decline of 92.8%.
- According to Business Quant data, Revenue for the three prior quarters was $389 million (Q1 2026), $678 million (Q4 2025) and $1.02 billion (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 22.97 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 25.31 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 16.99 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 16.61 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 14.41 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 15.38 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 10.05 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 7.80 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 15.03 Bn |
| 10 | Moderna | 85.93 Bn | 65.29 Bn | 52.00 Mn | 145.00 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 145.00 Mn |
| Mar 31, 2026 | 389.00 Mn |
| Dec 31, 2025 | 678.00 Mn |
| Sep 30, 2025 | 1.02 Bn |
| Jun 30, 2025 | 142.00 Mn |
| Mar 31, 2025 | 108.00 Mn |
| Dec 31, 2024 | 966.00 Mn |
| Sep 30, 2024 | 1.86 Bn |
| Jun 30, 2024 | 241.00 Mn |
| Mar 31, 2024 | 167.00 Mn |
| Dec 31, 2023 | 2.81 Bn |
| Sep 30, 2023 | 1.83 Bn |
| Jun 30, 2023 | 344.00 Mn |
| Mar 31, 2023 | 1.86 Bn |
| Dec 31, 2022 | 5.08 Bn |
| Sep 30, 2022 | 3.36 Bn |
| Jun 30, 2022 | 4.75 Bn |
| Mar 31, 2022 | 6.07 Bn |
| Dec 31, 2021 | 7.21 Bn |
| Sep 30, 2021 | 4.97 Bn |
Moderna Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "revenue", "ticker": "MRNA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=revenue&ticker=MRNA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();